Docetaxel-loading mixed micelle preparation and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANDONG UNIV
- Publication Date
- 2013-01-23
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a docetaxel-loaded mixed micelle preparation and a preparation method thereof. Background technique
[0002] Docetaxel (DTX), also known as docetaxel, is a new type of antineoplastic drug developed in recent years, and it is the second-generation synthetic drug of paclitaxel. The mechanism of action of docetaxel is similar to that of paclitaxel, and its anti-tumor activity is 1.3-12 times that of paclitaxel. It plays an anti-tumor effect by interfering with the microtubule network necessary for cell function during cell mitosis and division. Docetaxel can bind to free tubulin, promote the assembly of tubulin into stable microtubules, and inhibit its depolymerization, resulting in the loss of normal function of microtubule bundles and the fixation of microtubules, thereby inhibiting cell mitosis . It is clinically used in breast cancer, pancreatic cancer, non-small cell lung cancer, soft tissue sarcoma, head and neck cancer, g...